Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Advanced Solid Tumours × Irinotecan × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Colorectal Neoplasms 184 Colonic Neoplasms 80 Rectal Neoplasms 79 Stomach Neoplasms 52 Pancreatic Neoplasms 45 Esophageal Neoplasms 39 Neoplasms 38 Neoplasm Metastasis 33 Unspecified Adult Solid Tumor, Protocol Specific 29 Glioblastoma 26 Lung Neoplasms 25 Brain Neoplasms 23 Carcinoma, Non-Small-Cell Lung 21 Small Cell Lung Carcinoma 20 Central Nervous System Neoplasms 20 Glioma 19 Neuroblastoma 18 Adenocarcinoma Of Esophagus 17 Esophageal Squamous Cell Carcinoma 16 Gliosarcoma 15 Breast Neoplasms 14 Astrocytoma 14 Rhabdomyosarcoma 13 Sarcoma 11 Oligodendroglioma 10 Adenocarcinoma 9 Sarcoma, Ewing 8 Medulloblastoma 8 Gallbladder Neoplasms 8 Carcinoma, Hepatocellular 8

Interventions

Paclitaxel 3 olaparib 2 adavosertib 2 Fluorouracil 2 Carboplatin 2 durvalumab 1 danvatirsen 1 capivasertib 1 Pantoprazole 1 Leucovorin 1 Irinotecan 1 Injections 1 Gemcitabine 1 Doxorubicin 1 Cisplatin 1 AZD0156 1 130-nm albumin-bound paclitaxel 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02588105 2022-09-19

AToM

AstraZeneca

Phase 1 Completed

Other solid neoplasm

Advanced Solid Tumours

Data powered by HemOnc (CC BY 4.0) Colophon ⚡